John D. Hainsworth
- Oncology top 0.01%
- Pulmonary and Respiratory Medicine top 0.05%
- Molecular Biology top 0.2%
- Pathology and Forensic Medicine top 0.05%
- Surgery top 0.2%
- Co-authors
- F. Anthony GrecoHerbert I. HurwitzLouis FehrenbacherFairooz F. KabbinavarW. HeimWilliam NovotnyJordan BerlinEric Holmgren
- Topics
- Lung Cancer Research Studies (136 papers)Cancer Treatment and Pharmacology (119 papers)Lung Cancer Treatments and Mutations (118 papers)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
John D. Hainsworth
623 papers receiving 36.0k citations
Hit Papers
Peers
Comparison fields: 5 of 161
- Oncology 21.5k
- Pulmonary and Respiratory Medicine 12.3k
- Molecular Biology 10.1k
- Pathology and Forensic Medicine 7.0k
- Surgery 5.3k
Countries citing papers authored by John D. Hainsworth
This map shows the geographic impact of John D. Hainsworth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John D. Hainsworth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John D. Hainsworth more than expected).
Fields of papers citing papers by John D. Hainsworth
This network shows the impact of papers produced by John D. Hainsworth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John D. Hainsworth. The network helps show where John D. Hainsworth may publish in the future.
Co-authorship network of co-authors of John D. Hainsworth
This figure shows the co-authorship network connecting the top 25 collaborators of John D. Hainsworth. A scholar is included among the top collaborators of John D. Hainsworth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John D. Hainsworth. John D. Hainsworth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 56 | |
| 2 | 18 | |
| 3 | 6 | |
| 4 | Targeted Therapy for Advanced Solid Tumors on the Basis of Molecular Profiles: Results From MyPathway, an Open-Label, Phase IIa Multiple Basket Studybreakdown → | 357 |
| 5 | 12 | |
| 6 | 11 | |
| 7 | Early Relapse of Follicular Lymphoma After Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Defines Patients at High Risk for Death: An Analysis From the National LymphoCare Studybreakdown → | 509 |
| 8 | 5 | |
| 9 | Efficacy of Octreotide Long-Acting Repeatable (OCT) From the Phase III RADIANT-2 Study in Patients With Advanced Neuroendocrine Tumors (NET) : A Post-Hoc Analysis of the Placebo (PBO) Arm With Updated Survival Data | 1 |
| 10 | 154 | |
| 11 | 34 | |
| 12 | 138 | |
| 13 | Everolimus plus octreotide long-acting release (LAR) for the treatment of advanced neuroendocrine tumors (NET) associated with carcinoid syndrome (RADIANT-2) : Updated overall survival results | 2 |
| 14 | 135 | |
| 15 | Abstract #LB-131: Biomarker evaluation in the Phase III, placebo (P)-controlled, randomized BeTa trial of bevacizumab (B) and erlotinib (E) for patients (pts) with advanced non-small cell lung cancer (NSCLC) after failure of standard 1st-line chemotherapy: correlation with treatment outcomes | 1 |
| 16 | 7 | |
| 17 | 25 | |
| 18 | 61 | |
| 19 | 10 | |
| 20 | Carboplatin plus oral etoposide in the management of advanced, non-small cell lung cancer: preliminary results of a Vanderbilt trial. | 5 |
About John D. Hainsworth
John D. Hainsworth is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 631 papers that have together received 37.1k indexed citations. Recurring topics across this work include Lung Cancer Research Studies (136 papers), Cancer Treatment and Pharmacology (119 papers) and Lung Cancer Treatments and Mutations (118 papers). The work is most often cited by research in Oncology (21.5k citations), Pathology and Forensic Medicine (7.0k citations) and Pulmonary and Respiratory Medicine (12.3k citations). John D. Hainsworth has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include F. Anthony Greco, Herbert I. Hurwitz, Louis Fehrenbacher, Fairooz F. Kabbinavar, W. Heim, William Novotny, Jordan Berlin, Eric Holmgren, Thomas H. Cartwright and Howard A. Burris. Their work appears in journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.